"Global U.S. Continuous Glucose Monitoring (CGM) Market Overview:
Global U.S. Continuous Glucose Monitoring (CGM) Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global U.S. Continuous Glucose Monitoring (CGM) Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of U.S. Continuous Glucose Monitoring (CGM) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the U.S. Continuous Glucose Monitoring (CGM) Market:
The U.S. Continuous Glucose Monitoring (CGM) Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for U.S. Continuous Glucose Monitoring (CGM) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study U.S. Continuous Glucose Monitoring (CGM) Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, U.S. Continuous Glucose Monitoring (CGM) market has been segmented into:
Child population
Adult population
By Application, U.S. Continuous Glucose Monitoring (CGM) market has been segmented into:
Stomach
Back of the arm
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The U.S. Continuous Glucose Monitoring (CGM) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the U.S. Continuous Glucose Monitoring (CGM) market.
Top Key Players Covered in U.S. Continuous Glucose Monitoring (CGM) market are:
Abbott
Dexcom
Inc.
Senseonics Holdings
Inc.
Medtronic
Roche
A. Menarini Diagnostics s.r.l
Echo Therapeutics
Inc.
GlySens Incorporated.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: U.S. Continuous Glucose Monitoring (CGM) Market by Type
4.1 U.S. Continuous Glucose Monitoring (CGM) Market Snapshot and Growth Engine
4.2 U.S. Continuous Glucose Monitoring (CGM) Market Overview
4.3 Child population
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Child population: Geographic Segmentation Analysis
4.4 Adult population
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Adult population: Geographic Segmentation Analysis
Chapter 5: U.S. Continuous Glucose Monitoring (CGM) Market by Application
5.1 U.S. Continuous Glucose Monitoring (CGM) Market Snapshot and Growth Engine
5.2 U.S. Continuous Glucose Monitoring (CGM) Market Overview
5.3 Stomach
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Stomach: Geographic Segmentation Analysis
5.4 Back of the arm
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Back of the arm: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 U.S. Continuous Glucose Monitoring (CGM) Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 DEXCOM
6.4 INC.
6.5 SENSEONICS HOLDINGS
6.6 INC.
6.7 MEDTRONIC
6.8 ROCHE
6.9 A. MENARINI DIAGNOSTICS S.R.L
6.10 ECHO THERAPEUTICS
6.11 INC.
6.12 GLYSENS INCORPORATED.
Chapter 7: Global U.S. Continuous Glucose Monitoring (CGM) Market By Region
7.1 Overview
7.2. North America U.S. Continuous Glucose Monitoring (CGM) Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Child population
7.2.4.2 Adult population
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Stomach
7.2.5.2 Back of the arm
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe U.S. Continuous Glucose Monitoring (CGM) Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Child population
7.3.4.2 Adult population
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Stomach
7.3.5.2 Back of the arm
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe U.S. Continuous Glucose Monitoring (CGM) Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Child population
7.4.4.2 Adult population
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Stomach
7.4.5.2 Back of the arm
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific U.S. Continuous Glucose Monitoring (CGM) Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Child population
7.5.4.2 Adult population
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Stomach
7.5.5.2 Back of the arm
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa U.S. Continuous Glucose Monitoring (CGM) Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Child population
7.6.4.2 Adult population
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Stomach
7.6.5.2 Back of the arm
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America U.S. Continuous Glucose Monitoring (CGM) Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Child population
7.7.4.2 Adult population
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Stomach
7.7.5.2 Back of the arm
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
U.S. Continuous Glucose Monitoring (CGM) Scope:
|
Report Data
|
U.S. Continuous Glucose Monitoring (CGM) Market
|
|
U.S. Continuous Glucose Monitoring (CGM) Market Size in 2025
|
USD XX million
|
|
U.S. Continuous Glucose Monitoring (CGM) CAGR 2025 - 2032
|
XX%
|
|
U.S. Continuous Glucose Monitoring (CGM) Base Year
|
2024
|
|
U.S. Continuous Glucose Monitoring (CGM) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott, Dexcom, Inc., Senseonics Holdings, Inc., Medtronic, Roche, A. Menarini Diagnostics s.r.l, Echo Therapeutics, Inc., GlySens Incorporated..
|
|
Key Segments
|
By Type
Child population
Adult population
By Applications
Stomach
Back of the arm
|
